Skip to main content
padlock icon - secure page this page is secure

Antiretrovirals for Prevention: Realizing the Potential. Closing Commentary by the Executive Director of UNAIDS

Buy Article:

$68.00 + tax (Refund Policy)

Antiretroviral therapy (ART), for those who have access, has revolutionised the morbidity and mortality consequences of HIV infection. By the end of 2010, 6.6 million people living with HIV in low- and middle-income countries were receiving ART, a dramatic 20-fold increase since 2001, saving millions of lives. In addition to the impact of ART on the health of those living with HIV, recent randomised controlled trials demonstrate the additional impact of ART in reducing HIV transmission. With this double effect, ART is a game changer in the response to AIDS. With other advances over the past year, we now have a set of effective tools to stop the transmission of the virus and to keep people living with HIV healthy and productive. It is now the collective responsibility of researchers and implementers, of governments, the private sector and civil society, to identify and overcome the challenges and translate the science into real results for people. At the recent United Nations High Level Meeting on AIDS, Member States endorsed ambitious targets including to reach 15 million people living with HIV with ART and to cut sexual transmission of HIV by half by 2015. The declaration also calls for additional resources of 22 to 24 billion dollars by 2015 as an investment that will yield returns in multiples.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Antiretrovirals; HIV; HIV prevalence; HIV prevention; HIV treatment; HIV treatment for prevention; Pre-exposure; Treatment 2.0; UNAIDS; investment

Document Type: Research Article

Publication date: September 1, 2011

More about this publication?
  • Current HIV Research aims to cover all the latest and outstanding developments of HIV research. We invite comprehensive review articles and novel, pioneering work in the basic and clinical fields on all areas of HIV research, including virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Each issue of the journal contains a series of timely in-depth reviews and original research written by leaders in the field covering a range of current topics on HIV research. Periodically, the journal will invite guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more